Citation: Zhang Lei, Liu Lai, Zheng Chengyue, Wang Yang, Wang Jing, Yao Qizheng. Synthesis of Novel Indirubin Derivatives and Their Effects on the Proliferation, Cell Cycle and Apoptosis in Acute Myeloblastic Leukemia HL-60 Cells[J]. Chinese Journal of Organic Chemistry, ;2017, 37(6): 1523-1529. doi: 10.6023/cjoc201704018 shu

Synthesis of Novel Indirubin Derivatives and Their Effects on the Proliferation, Cell Cycle and Apoptosis in Acute Myeloblastic Leukemia HL-60 Cells

Zhang Lei ^a,*,, ,
Liu Lai ^a ,
Zheng Chengyue ^a ,
Wang Yang ^a ,
Wang Jing ^a,*,, ,
Yao Qizheng ^b

a.
School of Pharmacy, Zunyi Medical University, Zunyi 563003
b.
School of Pharmacy, China Pharmaceutical University, Nanjing 210009

Corresponding author: Zhang Lei, lzhang@zmc.edu.cn Wang Jing, wangjing@zmc.edu.cn
Received Date: 12 April 2017
Revised Date: 28 April 2017

Fund Project: the Undergraduate Training Programs for Innovation and Entrepreneurship of Zunyi Medical University [2014]5811the Department of Science and Technology of Guizhou Province [2014]7565the Discipline Construction Funding Medicinal Chemistrythe Undergraduate Training Programs for Innovation and Entrepreneurship of Zunyi Medical University [2014]2918the Department of Science and Technology of Guizhou Province [2014]7557the National Undergraduate Training Programs for Innovation and Entrepreneurship 201510661009the Priming Scientific Research Foundation for Doctoral Program of Zunyi Medical University F-631

Figures(7)

Acute myelogenous leukemia is a malignant disease of the hemopoietic tissue, which causes great harm to human health, and there is no therapeutic drugs with low toxicity and high efficiency. Indirubin is the active constituent of the traditional chinese medicine qingdai, which has potential anti-leukemia activity. However, poor water solubility and low bioavailability have limited its clinical treatment. To improve the water solubility and anti-leukemia activity of indirubin, hydrophilic amino side chain was linked to the indirubin, and five novel indirubin derivatives were synthesized, which were identified by HRMS, ¹H NMR and ¹³C NMR. Meanwhile, the effects of target molecules on the proliferation of acute myeloblastic leukemia HL-60 cells were evaluated using CCK-8 assay. The results showed that four derivatives displayed potent antiproliferative activity against HL-60 cells. Notably, N¹-(2-dimethylaminoethyl)indirubin (5a) exhibited the best anticacner activity with an IC₅₀ value of (3.564±0.211) μmol/L. Flow cytometry and Hoechst 33342 staining indicated that compound 5a could significantly trigger cell cycle arrest and induce apoptosis of HL-60 cells. Finally, compound 5a could regulate the levels of cell cycle arrest-and apoptosis-related proteins. Together, these findings revealed that compound 5a maybe be a promising lead candidate for the treatment of leukemia.
- indirubin,
- derivatives,
- anticancer activity,
- cell cycle,
- cell apoptosis,
- HL-60 leukemia cells
1. [1]
  Döhner, H.; Estey, E. H.; Amadori, S.; Appelbaum, F. R.; Büchner, T.; Burnett, A. K.; Dombret, H.; Fenaux, P.; Grimwade, D.; Larson, R. A.; Lo-Coco, F.; Naoe, T.; Niederwieser, D.; Ossenkoppele, G. J.; Sanz, M. A.; Sierra, J.; Tallman, M. S.; Löwenberg, B.; Bloomfield, C. D. Blood 2010, 115, 453. doi: 10.1182/blood-2009-07-235358
2. [2]
  Ofran, Y.; Rowe J. M. Acta Haematol. 2014, 132, 292. doi: 10.1159/000360200
3. [3]
  Choi, T. Y.; Lee, M. S.; Ernst, E. Support. Care Cancer 2015, 23, 1819. doi: 10.1007/s00520-014-2530-7
4. [4]
  Cai, J.; Damaraju, V. L.; Groulx, N.; Mowles, D.; Peng, Y.; Robins, M. J.; Cass, C. E.; Gros, P. Cancer Res. 2008, 68, 2349. doi: 10.1158/0008-5472.CAN-07-5528
5. [5]
  Xiao, Z.; Hao, Y.; Liu, B.; Qian, L. Leukocyte Lymph. 2002, 43, 1763. doi: 10.1080/1042819021000006295
6. [6]
  Gaboriaud-Kolar, N.; Vougogiannopoulou, K.; Skaltsounis, A. L. Expert Opin. Ther. Patents 2015, 25, 583. doi: 10.1517/13543776.2015.1019865
7. [7]
  Ponnusamy, K.; Petchiammal, C.; Mohankumar, R.; Hopper, W. J. Ethnopharmacol. 2010, 132, 349. doi: 10.1016/j.jep.2010.07.050
8. [8]
  Hsieh, W. L.; Lin, Y. K.; Tsai, C. N.; Wang, T. M.; Chen, T. Y.; Pang, J. H. S. J. Dermatol. Sci. 2012, 67, 140. doi: 10.1016/j.jdermsci.2012.05.008
9. [9]
  Mak, N. K.; Leung, C. Y.; Wei, X. Y.; Shen, X. L.; Wong, R. N. S.; Leung, K. N.; Fung, M. C. Biochem. Pharmacol. 2004, 67, 167. doi: 10.1016/j.bcp.2003.08.020
10. [10]
  Kunikata, T.; Tatefuji, T.; Aga, H.; Iwaki, K.; Ikeda, M.; Kurimoto, M. Eur. J. Pharmacol. 2000, 410, 93. doi: 10.1016/S0014-2999(00)00879-7
11. [11]
  Zhang, X.; Song, Y.; Wu, Y.; Dong, Y.; Lai, L.; Zhang, J.; Lu, B.; Dai, F.; He, L.; Liu, M.; Yi, Z. Int. J. Cancer 2011, 129, 2502. doi: 10.1002/ijc.v129.10
12. [12]
  Suzuki, K.; Adachi, R.; Hirayama, A.; Watanabe, H.; Otani, S.; Watanabe, Y.; Kasahara, T. Brit. J. Haematol. 2005, 130, 681. doi: 10.1111/bjh.2005.130.issue-5
13. [13]
  Gu, Y. C.; Li, G. L.; Yang, Y. P.; Fu, J. P.; Li, C. Z. Acta Pharm. Sinica 1989, 24, 629 (in Chinese).
14. [14]
  Hsuan, S. L.; Chang, S. C.; Wang, S. Y.; Liao, T. L.; Jong, T. T.; Chien, M. S.; Lee, W. C.; Chen, S. S.; Liao, J. W. J. Ethnopharmacol. 2009, 123, 61. doi: 10.1016/j.jep.2009.02.028
15. [15]
  Hoessel, R.; Leclerc, S.; Endicott, J. A.; Nobel, M. E. M.; Lawrie, A.; Tunnah, P.; Leost, M.; Damiens, E.; Marie, D.; Marko, D.; Niederberger, E.; Tang, W.; Eisenbrand, G.; Meijer, L. Nat. Cell Biol. 1999, 1, 60. doi: 10.1038/9035
16. [16]
  Vougogiannopoulou, K.; Ferandin. Y.; Bettayeb, K.; Myrianthopoulos, V.; Lozach, O.; Fan, Y.; Johnson, C. H.; Magiatis, P.; Skaltsounis, A. L.; Mikros, E.; Meijer, L. J. Med. Chem. 2008, 51, 6421. doi: 10.1021/jm800648y
17. [17]
  Song, J. H.; Lee, J. E.; Cho, K. M.; Park, S. H.; Kim, H. J.; Kim, Y. C.; Kim, T. S. Mol. Carcinog. 2016, 55, 611. doi: 10.1002/mc.22307
18. [18]
  Libnow, S.; Methling, K.; Hein, M.; Michalik, D.; Harms, M.; Wende, K.; Flemming, A.; Köckerling, M.; Reinke, H.; Bednarski, P. J.; Lalk, M.; Langer, P. Bioorg. Med. Chem. 2008, 16, 5570. doi: 10.1016/j.bmc.2008.04.003
19. [19]
  Cheng, X.; Rasqué, P.; Vatter, S.; Merz, K. H.; Eisenbrand, G. Bioorg. Med. Chem. 2010, 18, 4509. doi: 10.1016/j.bmc.2010.04.066
20. [20]
  Wang, T. C.; Wei, J. Z.; Guo, C. S.; Zhang, H. B.; Fan, H. X. Chin. Chem. Lett. 2010, 21, 1407. doi: 10.1016/j.cclet.2010.05.026
21. [21]
  Wang, Z. H.; Li, W. Y.; Li, F. L.; Zhang, L.; Hua, W. Y.; Cheng, J. C.; Yao, Q. Z. Chin. Chem. Lett. 2009, 20, 542. doi: 10.1016/j.cclet.2008.12.011
22. [22]
  Wang, Z.; Wang, Y.; Feng, M.; Tan, X.; Cheng, J.; Hua, W.; Yao, Q. Chin. J. Org. Chem. 2009, 29, 1606 (in Chinese).
23. [23]
  Wang, Z. H.; Dong, Y.; Wang, T.; Shang, M. H.; Hua, W. Y.; Yao, Q. Z. Chin. Chem. Lett. 2010, 21, 297. doi: 10.1016/j.cclet.2009.11.029
24. [24]
  Cragg, G. M.; Grothaus, P. G.; Newman, D. J. Chem. Rev. 2009, 109, 3012. doi: 10.1021/cr900019j
25. [25]
  Evan, G. I.; Vousden, K. H. Nature 2001, 411, 342. doi: 10.1038/35077213
26. [26]
  Fesik, S. W. Nat. Rev. Cancer 2005, 5, 876. doi: 10.1038/nrc1736
27. [27]
  Klöcka, C.; Jin, X.; Choi, K.; Khosla, C.; Madrid, P. B.; Spencer, S.; Raimundo, B. C.; Boardman, P.; Lanza, G.; Griffin, J. H. Bioorg. Med. Chem. Lett. 2011, 21, 2692. doi: 10.1016/j.bmcl.2010.12.037
28. [28]
  Zhang, L.; Zhang, Z.; Chen, F.; Chen, Y.; Lin, Y.; Wang, J. Eur. J. Med. Chem. 2016, 123, 226. doi: 10.1016/j.ejmech.2016.07.050
29. [29]
  Zhang, L.; Liu, L.; Zheng, C.; Wang, Y.; Nie, X.; Shi, D.; Chen, Y.; Wei, G.; Wang, J. Eur. J. Med. Chem. 2017, 131, 81. doi: 10.1016/j.ejmech.2017.03.011
1. [1]
  Jing WU , Puzhen HUI , Huilin ZHENG , Pingchuan YUAN , Chunfei WANG , Hui WANG , Xiaoxia GU . Synthesis, crystal structures, and antitumor activities of transition metal complexes incorporating a naphthol-aldehyde Schiff base ligand. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2422-2428. doi: 10.11862/CJIC.20240278
2. [2]
  Zhaoxin LI , Ruibo WEI , Min ZHANG , Zefeng WANG , Jing ZHENG , Jianbo LIU . Advancements in the construction of inorganic protocells and their cell mimic and bio-catalytical applications. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2286-2302. doi: 10.11862/CJIC.20240235
3. [3]
  Shuyu Liu , Xiaomin Sun , Bohan Song , Gaofeng Zeng , Bingbing Du , Chongshen Guo , Cong Wang , Lei Wang . Design and Fabrication of Phospholipid-Vesicle-based Artificial Cells towards Biomedical Applications. University Chemistry, 2024, 39(11): 182-188. doi: 10.12461/PKU.DXHX202404113
4. [4]
  Siyi ZHONG , Xiaowen LIN , Jiaxin LIU , Ruyi WANG , Tao LIANG , Zhengfeng DENG , Ao ZHONG , Cuiping HAN . Targeting imaging and detection of ovarian cancer cells based on fluorescent magnetic carbon dots. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1483-1490. doi: 10.11862/CJIC.20240093
5. [5]
  Shipeng WANG , Shangyu XIE , Luxian LIANG , Xuehong WANG , Jie WEI , Deqiang WANG . Piezoelectric effect of Mn, Bi co-doped sodium niobate for promoting cell proliferation and bacteriostasis. Chinese Journal of Inorganic Chemistry, 2024, 40(10): 1919-1931. doi: 10.11862/CJIC.20240094
6. [6]
  Peng GENG , Guangcan XIANG , Wen ZHANG , Haichuang LAN , Shuzhang XIAO . Hollow copper sulfide loaded protoporphyrin for photothermal-sonodynamic therapy of cancer cells. Chinese Journal of Inorganic Chemistry, 2024, 40(10): 1903-1910. doi: 10.11862/CJIC.20240155
7. [7]
  Yao HUANG , Yingshu WU , Zhichun BAO , Yue HUANG , Shangfeng TANG , Ruixue LIU , Yancheng LIU , Hong LIANG . Copper complexes of anthrahydrazone bearing pyridyl side chain: Synthesis, crystal structure, anticancer activity, and DNA binding. Chinese Journal of Inorganic Chemistry, 2025, 41(1): 213-224. doi: 10.11862/CJIC.20240359
8. [8]
  Jianfeng Yan , Yating Xiao , Xin Zuo , Caixia Lin , Yaofeng Yuan . Comprehensive Chemistry Experimental Design of Ferrocenylphenyl Derivatives. University Chemistry, 2024, 39(4): 329-337. doi: 10.3866/PKU.DXHX202310005
9. [9]
  Ping Song , Nan Zhang , Jie Wang , Rui Yan , Zhiqiang Wang , Yingxue Jin . Experimental Teaching Design on Synthesis and Antitumor Activity Study of Cu-Pyropheophorbide-a Methyl Ester. University Chemistry, 2024, 39(6): 278-286. doi: 10.3866/PKU.DXHX202310087
10. [10]
  Di WU , Ruimeng SHI , Zhaoyang WANG , Yuehua SHI , Fan YANG , Leyong ZENG . Construction of pH/photothermal dual-responsive delivery nanosystem for combination therapy of drug-resistant bladder cancer cell. Chinese Journal of Inorganic Chemistry, 2024, 40(9): 1679-1688. doi: 10.11862/CJIC.20240135
11. [11]
  Xinyu ZENG , Guhua TANG , Jianming OUYANG . Inhibitory effect of Desmodium styracifolium polysaccharides with different content of carboxyl groups on the growth, aggregation and cell adhesion of calcium oxalate crystals. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1563-1576. doi: 10.11862/CJIC.20230374
12. [12]
  Yonghui ZHOU , Rujun HUANG , Dongchao YAO , Aiwei ZHANG , Yuhang SUN , Zhujun CHEN , Baisong ZHU , Youxuan ZHENG . Synthesis and photoelectric properties of fluorescence materials with electron donor-acceptor structures based on quinoxaline and pyridinopyrazine, carbazole, and diphenylamine derivatives. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 701-712. doi: 10.11862/CJIC.20230373
13. [13]
  Yikai Wang , Xiaolin Jiang , Haoming Song , Nan Wei , Yifan Wang , Xinjun Xu , Cuihong Li , Hao Lu , Yahui Liu , Zhishan Bo . 氰基修饰的苝二酰亚胺衍生物作为膜厚不敏感型阴极界面材料用于高效有机太阳能电池. Acta Physico-Chimica Sinica, 2025, 41(3): 2406007-. doi: 10.3866/PKU.WHXB202406007
14. [14]
  Haitang WANG , Yanni LING , Xiaqing MA , Yuxin CHEN , Rui ZHANG , Keyi WANG , Ying ZHANG , Wenmin WANG . Construction, crystal structures, and biological activities of two Ln^Ⅲ₃ complexes. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1474-1482. doi: 10.11862/CJIC.20240188
15. [15]
  Xin MA , Ya SUN , Na SUN , Qian KANG , Jiajia ZHANG , Ruitao ZHU , Xiaoli GAO . A Tb₂ complex based on polydentate Schiff base: Crystal structure, fluorescence properties, and biological activity. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1347-1356. doi: 10.11862/CJIC.20230357
16. [16]
  Hongling Liu , Yue Xia , Guang Xu , Yafei Yang , Chunhua Qu . Bitter Cold Medicine, Good for Healing. University Chemistry, 2025, 40(3): 328-332. doi: 10.12461/PKU.DXHX202405039
17. [17]
  Aiai WANG , Lu ZHAO , Yunfeng BAI , Feng FENG . Research progress of bimetallic organic framework in tumor diagnosis and treatment. Chinese Journal of Inorganic Chemistry, 2024, 40(10): 1825-1839. doi: 10.11862/CJIC.20240225
18. [18]
  Tingting XU , Wenjing ZHANG , Yongbo SONG . Research advances of atomic precision coinage metal nanoclusters in tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2275-2285. doi: 10.11862/CJIC.20240229
19. [19]
  Jiahui CHEN , Tingting ZHENG , Xiuyun ZHANG , Wei LÜ . Research progress of near-infrared absorption inorganic nanomaterials in photothermal and photodynamic therapy of tumors. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2396-2414. doi: 10.11862/CJIC.20240106
20. [20]
  Weina Wang , Fengyi Liu , Wenliang Wang . “Extracting Commonality, Delving into Typicals, Deriving Individuality”: Constructing a Knowledge Graph of Crystal Structures. University Chemistry, 2024, 39(3): 36-42. doi: 10.3866/PKU.DXHX202308029

Get Citation

PDF

XML

Metrics

PDF Downloads(3)
Abstract views(2049)
HTML views(403)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142